Tezosentan in Patients With Pulmonary Arterial Hypertension

Summary

Multicenter, double-blind, randomized, placebo-controlled, cross-over study to demonstrate that a single infusion of tezosentan has minimal effect on blood pressure in patients with pulmonary arterial hypertension, treated with endothelin receptor antagonists, phosphodiesterase-5 inhibitors or a combination of both.

Timeline

Start

2010-09-01

Primary completion

2010-12-01

Completion

2011-09-01

Outcome

Outcome not reported

Stopped (Enrollment): “Due to slow recruitment, the study was prematurely discontinued.”

Drugs

Indications